Compare ADMA Biologics Inc (ADMA) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Stryker Corporation — how do they compare? ADMA Biologics Inc trades at $9.84 (market cap $2.22B), while Stryker Corporation trades at $340.6 (market cap $133.54B). The key difference: Stryker Corporation is far larger — about 60.2× ADMA Biologics Inc's market cap, and Stryker Corporation pays a 1.01% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | SYK | |
|---|---|---|
Market Cap | $2.22B | $133.54B |
Sector | Health | Technology |
52-Week High | $20.38 | $394.34 |
52-Week Low | $7.60 | $282.58 |
Enterprise Value | $2.29B | $145.01B |
Dividend Yield | — | 1.01% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
